Diuretic therapy for newborn infants with posthemorrhagic ventricular dilatation

Cochrane Database of Systematic Reviews

Volumn 2010, Issue 1, 2001, Pages

  Whitelaw, Andrew ^a   Brion, Luc P ^b   Kennedy, Colin R ^c   Odd, David ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; DIURETIC AGENT; FUROSEMIDE;

BRAIN HEMORRHAGE; BRAIN VENTRICLE; BRAIN VENTRICLE PERITONEUM SHUNT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; HUMAN; HYDROCEPHALUS; INFANT; LESIONS AND DEFECTS; NEWBORN; RANDOMIZED CONTROLLED TRIAL; REVIEW;

ACETAZOLAMIDE; CEREBRAL HEMORRHAGE; CEREBRAL VENTRICLES; DILATATION, PATHOLOGIC; DIURETICS; FUROSEMIDE; HUMANS; HYDROCEPHALUS; INFANT; INFANT, NEWBORN; RANDOMIZED CONTROLLED TRIALS; VENTRICULOPERITONEAL SHUNT;

EID: 19244387138     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD002270     Document Type: Article

References (24)

1. Libenson MH, Kaye EM, Rosman NP, Gilmore HE. Acetazolamide and furosemide for posthemorrhagic hydrocephalus of the newborn. Pediatric Neurology 1999;20:185-91.
2. Stafstrom CE, Gilmore HE, Kurtin PS. Nephrocalcinosis complicating medical treatment of posthemorrhagic hydrocephalus. Pediatric Neurology 1992;8:179-82.
3. International PHVD Drug Trial Group. International randomised controlled trial of acetazolamide and frusemide in posthaemorrhagic ventricular dilatation of infancy. Lancet 1998;352:433-40.
4. Kennedy CR, Ayers S, Campbell MJ, Elbourne D, Hope P, Johnson A. Randomized, controlled trial of acetazolamide and furosemide in posthemorrhagic ventricular dilatation in infancy: follow-up at 1 year. Pediatrics 2001;108:597-607.
5. Birzis L, Carter CH, Maren TH. The effect of acetazolamide on CSF pressure and electrolytes in hydrocephalus. Neurology 1958;8:522-8.
6. Cammer WB, Brion LP. Carbonic anhydrases in nervous tissue. In: WR Chegwidden, ND Carter, YH Edwards editor(s). The carbonic anhydrases: New Horizons. Basel: Birkhäuser Verlag, 2000:475-89.
7. Chaplin ER, Goldstein GW, Myerberg DZ, Hunt JV, Tooley WH. Posthemorrhagic hydrocephalus in the preterm infant. Pediatrics 1980;65:901-9.
8. Cordoba E, Gerhardt T, Rojas M, Duara S, Bancalari E. Comparison of the effects of acetazolamide and aminophylline on apnea incidence and on ventilatory response to CO2 in preterm infants. Pediatric Pulmonology 1994;17:291-5.
9. Cowan F, Whitelaw A. Acute effects of acetazolamide on cerebral blood flow velocity and pCO2 in the newborn infant. Acta Paediatrica Scandinavia 1991;80:22-7.
10. Donat JF. Acetazolamide-induced improvement in hydrocephalus. Archives of Neurology 1980;37:376.
11. du Plessis AJ. Posthemorrhagic hydrocephalus and brain injury in the preterm infant: dilemmas in diagnosis and managment. Seminars in Pediatric Neurology 1998;5:161-79.
12. Huttenlocher PR. Treatment of hydrocephalus with acetazolamide. The Journal of Pediatrics 1965;66:1023-30.
13. Mealey J Jr, Barker DT. Failure of oral acetazolamide to avert hydrocephalus in infants with meningomyeocele. The Journal of Pediatrics 1968;72:257-9.
14. Ment LR, Vohr B, Allan W, Westerveld M, Katz KH, Schneider KC, Makuch RW. The etiology and outcome of cerebral ventriculomegaly at term in very low birth weight preterm infants. Pediatrics 1999;104:243-8.
15. Mercuri E, Faundez JC, Cowan F, Dubowitz L. Acetazolamide without frusemide in the treatment of post-haemorrhagic hydrocephalus. Acta Paediatrica 1994;83:1319-21.
16. Schain RJ. Carbonic anhydrase inhibitors in chronic infantile hydrocephalus. American Journal of Diseases of Children 1969;117:621-5.
17. Schoeman J, Donald P, Van Zyl L, Keet M, Wait J. Tuberculous hydrocephalus: comparison of different treatments with regard to ICP, ventricular size and clinical outcome. Developmental Medicine and Child Neurology 1991;33:396-405.
18. Shinnar S, Gammon K, Bergman EW, Epstein M, Freeman JM. Management of hydrocephalus in infancy: Use of acetazolamide and furosemide to avoid cerebrospinal fluid shunts. Journal of Pediatrics 1985;107:31-7.
19. Volpe JJ. Neurology of the Newborn. 3rd Edition. Philadelphia: Saunders, 1995:403-63.
20. Whitelaw A. Neonatal hydrocephalus-clinical assessment and non-surgical treatment. In: Levene MI, Lilford RJ editor(s). Fetal and neonatal neurology and neurosurgery. 2nd Edition. Edinburgh: Churchill Livingstone, 1995:645-60.
21. Whitelaw A. Repeated lumbar or ventricular punctures for preventing disability or shunt dependence in newborn infants with intraventricular hemorrhage. Cochrane Database of Systematic Reviews 1999, Issue 4.
22. Whitelaw A. Intraventricular streptokinase after intraventricular hemorrhage in newborn infants. Cochrane Database of Systematic Reviews 1999, Issue 4.
23. Whitelaw A, Christie S, Pople I. Transforming growth factor beta-1: a possible signal molecule for post-haemorrhagic hydrocephalus?. Pediatric Research 1999;46:576-80.
24. Whitelaw A, Kennedy CR, Brion LP. Diuretic therapy for newborn infants with posthemorrhagic ventricular dilatation. Cochrane Database of Systematic Reviews 2001, Issue 2.